Copyright Notice This presentation is copyrighted by the
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The contents of the presentation may be modified, but the Psychopharmacology Institute logo must remain visible in all slides.
A Treatment Algorithm for TRD Prof. Philip Cowen Professor of Psychopharmacology Department of Psychiatry University of Oxford, UK
Treatment algorithm for TRD
Treatment algorithm for TRD Every patient requires an individual assessment • Treatment history • Symptoms • Extent of their disability
Treatment algorithm for TRD Every patient requires an individual assessment • Treatment history • Symptoms • Extent of their disability
Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323.
First line: Escitalopram Venlafaxine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323.
First line: Escitalopram: 20 mg/day Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323.
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323.
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323. Atypical antipsychotics
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Atypical antipsychotics Mirtazapine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323.
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Atypical antipsychotics Mirtazapine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323. Lithium
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Mirtazapine TCAs Amitriptyline Atypical antipsychotics Clomipramine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323. Lithium
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Mirtazapine TCAs Amitriptyline Atypical antipsychotics Clomipramine MAOI Phenelzine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323. Tryptophan Lithium
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Mirtazapine TCAs Amitriptyline Atypical antipsychotics Clomipramine MAOI Phenelzine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323. Tryptophan ECT Lithium
First line: Escitalopram: 20 Venlafaxine: up to mg/day 375 mg/day Mirtazapine TCAs Amitriptyline Atypical antipsychotics Lithium Psychotherapy Clomipramine CBT MBCBT MAOI Phenelzine Cowen PJ, Anderson IM (2015). New approaches to treating resistant depression. BJPsych Advances 21, 315 -323. Tryptophan ECT
End of presentations
- Slides: 17